HLA-A*32:01 and Lamotrigine-Induced DRESS—From Genetic Association to Clinical Implementation - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Genetic Link Between HLA-A*32:01 and Lamotrigine-Related DRESS: Insights for Clinical Practice

  • By

  • Kun Lin Lu

  • September 2, 2026

Share

Clinical Scorecard: Genetic Link Between HLA-A*32:01 and Lamotrigine-Related DRESS: Insights for Clinical Practice

At a Glance

CategoryDetail
ConditionDrug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
Key MechanismsAssociation of HLA-A*32:01 with increased odds of DRESS in lamotrigine users.
Target PopulationPredominantly White individuals taking lamotrigine.
Care SettingPharmacogenomics in neurology and psychiatry practice.

Key Highlights

  • HLA-A*32:01 carriage in 41.4% of DRESS cases vs. 4.1% in controls.
  • Increased odds of DRESS associated with HLA-A*32:01 (OR 16.4).
  • Concurrent acute liver injury observed in 69.0% of DRESS cases.
  • Routine screening for HLA-A*32:01 may not be sufficient for predicting DRESS.
  • Positive predictive value of HLA-A*32:01 screening estimated at 0.7%.

Guideline-Based Recommendations

Diagnosis

  • Consider HLA-A*32:01 testing in patients prescribed lamotrigine.

Management

  • Monitor for signs of DRESS in patients with HLA-A*32:01.

Monitoring & Follow-up

  • Assess medication history and causality in suspected DRESS cases.

Risks

  • HLA-A*32:01 is neither required nor sufficient for predicting DRESS.

Patient & Prescribing Data

Individuals prescribed lamotrigine, particularly those with a history of hypersensitivity reactions.

Genotype-guided prescribing may improve outcomes but requires further validation.

Clinical Best Practices

  • Implement structured causality assessment for suspected DRESS cases.
  • Consider polypharmacy effects when evaluating DRESS risk.
  • Conduct independent replication studies across diverse populations.

Related Resources & Content

Original Source(s)

HLA-A*32:01 and Lamotrigine-Induced DRESS—From Genetic Association to Clinical Implementation

  • by Kun Lin Lu

  • September 2, 2026

Related Content

Medical Oddities: Dogs share our mortality markers

The bond with dogs runs deeper, the brain enjoys a good sweat, love on screen gets real, and tea carries a little more weight.

FDA approves oral dermatomyositis therapy

Phase 3 findings show improvements in physical function and skin disease activity.

What happens to clinical skills when AI does the routine work?

“The need to be extra vigilant when you're reviewing something versus doing it from scratch can be a real problem.”